Price competition for generic drugs linked to increase in manufacturing-related recalls

Researchers have found that extreme price competition in the generic pharmaceutical market — designed to make medications more affordable — may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by manufacturing-related problems.